About
CAR T Therapies for Cancer
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
1,299
By Phase
PHASE1: 8PHASE1/PHASE2: 2PHASE3: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 4RECRUITING: 3UNKNOWN: 3ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
Today
Hover over trial bars to see details
Recent Trials
NCT04991948Lead Sponsor
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
PHASE1Recruiting
34 participants
Started: Nov 22, 2021 · Completed: May 25, 2038
NCT04613557Lead Sponsor
Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1Active, not recruiting
18 participants
Started: Nov 16, 2020 · Completed: Feb 28, 2037
NCT04167696Lead Sponsor
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
PHASE1Recruiting
27 participants
Started: Nov 25, 2019 · Completed: Feb 28, 2035
NCT03612739Lead Sponsor
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2
PHASE1Withdrawn
Started: Dec 31, 2018 · Completed: Aug 31, 2021
NCT03692429Lead Sponsor
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
PHASE1Recruiting
49 participants
Started: Nov 28, 2018 · Completed: Feb 17, 2036
Locations (1)
Headquarters
Mont-Saint-Guibert, Belgium
Map
Loading map...